首页> 外文期刊>Clinical and experimental hypertension: CEH >Pathogenesis of atherosclerosis in diabetes and hypertension.
【24h】

Pathogenesis of atherosclerosis in diabetes and hypertension.

机译:糖尿病和高血压中动脉粥样硬化的发病机理。

获取原文
获取原文并翻译 | 示例
           

摘要

Prevalence of atherosclerotic vascular disease is markedly increased among individuals with diabetes-mellitus and hypertension. Its major clinical manifestations are consequences of atherosclerosis of coronary arteries, cerebral arteries and large arteries of lower extremities. Thus, atherosclerotic vascular disease is the major cause of mortality and significant morbidity in diabetes and hypertension. Dyslipidemia, hyperinsulinemia, and central obesity seem to be associated with increased risk of atherosclerosis, along with the development of hypertension and diabetes (NIDDM). Insulin resistance is the fundamental factor in this situation which has strong genetic predisposition. Accelerated atherosclerosis in diabetes due to mechanism unique to diabetes like non-enzymatic glycation of proteins, oxidative modification of lipoproteins, formation of lipoproteins immune complexes, lipoproteins aggregation, disturbances of cell replication and growth factors and propensity to thrombosis are clearly established. Therapeutic implication for the prevention of atherosclerosis in diabetes and hypertension clearly emphasizes the need to achieve tight control of hyperglycemia, hypertension, and hyperlipidemia in addition to avoiding cigarette smoking and developing obesity.
机译:在患有糖尿病和高血压的个体中,动脉粥样硬化性血管疾病的患病率明显增加。它的主要临床表现是冠状动脉,脑动脉和下肢大动脉的动脉粥样硬化的后果。因此,动脉粥样硬化性血管疾病是导致糖尿病和高血压的死亡率和高发病率的主要原因。血脂异常,高胰岛素血症和中心性肥胖似乎与动脉粥样硬化的风险增加以及高血压和糖尿病(NIDDM)的发展有关。胰岛素抵抗是这种情况下具有强大遗传易感性的基本因素。明确建立了由于糖尿病独特的机制导致的糖尿病动脉粥样硬化,例如蛋白质的非酶糖基化,脂蛋白的氧化修饰,脂蛋白免疫复合物的形成,脂蛋白聚集,细胞复制和生长因子的紊乱以及血栓形成的倾向。预防糖尿病和高血压的动脉粥样硬化的治疗意义明确强调,除了避免吸烟和发展肥胖外,还必须严格控制高血糖,高血压和高血脂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号